Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01501032

Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes

Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this feasibility study is to evaluate the MDLAP (MD-Logic Artificial Pancreas system)automated insulin management system using continuous glucose monitoring (CGM) and subcutaneous insulin pump infusion in individuals with type 1 diabetes. The study will include 3 inpatient admissions (12-24 hr), which will include overnight sleep, over-bolus meal, under-bolus meal and exercise.

Detailed description

The purpose of this feasibility study is to evaluate the MDLAP (MD-Logic artificial pancreas system)automated insulin management system using continuous glucose monitoring (CGM) and subcutaneous insulin pump infusion in individuals with type 1 diabetes. The study will include 3 inpatient admissions (12-24 hr), which will include overnight sleep, over-bolus meal, under-bolus meal and exercise. During the the visits, meal boluses will be semi-automated, with manual meal announcement by the physician/nurse, automated bolus recommendation by the system, and automated delivery of the bolus following confirmation of the recommendation. Between-meal insulin dosing will be fully automated. Bolus confirmation by the physician/nurse will be requested by the closed loop controller only when it determines that carbohydrates may be necessary to avoid hypoglycemia following the bolus.

Conditions

Interventions

TypeNameDescription
DEVICEMD-logic artificial pancreas systemThe MD-logic artificial pancreas system is a closed loop control system using continuous glucose monitoring (CGM)and subcutaneous insulin pump infusion to mange glucose control in individuals with type 1 diabetes

Timeline

Start date
2013-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-12-29
Last updated
2015-03-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01501032. Inclusion in this directory is not an endorsement.